Tacrolimus inhibits oral carcinogenesis through cell cycle control

Tacrolimus inhibits oral carcinogenesis through cell cycle control

Tacrolimus (TAC, FK506) is a major calcineurin inhibitor and has been commonly used in treatments of patients with organ transplants and immune diseases. Moreover, tacrolimus is recommended by the treatment guidelines for oral potentially malignant disorders (OPMDs) such as oral lichen planus (OLP)....

Full description

Bibliographic Details
Main Authors: Yuanyuan Li, Yanting Wang, Jie Li, Zihang Ling, Wei Chen, Liping Zhang, Qinchao Hu, Tong Wu, Bin Cheng, Yun Wang, Juan Xia
Format: Article
Language:English
Published: Elsevier 2021-07-01
Series:Biomedicine & Pharmacotherapy
Subjects:
Tacrolimus
Oral squamous cell carcinoma
Carcinogenesis
Proliferation
Cell cycle
Online Access:http://www.sciencedirect.com/science/article/pii/S0753332221003309

Internet

http://www.sciencedirect.com/science/article/pii/S0753332221003309

Similar Items